Search Results - Venner, Chritopher

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Evaluation and Dilution Verification of the Optilite FreeliteTM Assay show discordant results at high serum free light chain concentrations

    Evaluation and Dilution Verification of the Optilite FreeliteTM Assay show discordant results at high serum free light chain concentrations by Agbor, Terence A., Parker, Michelle, Kyle, Barry, Sandhu, Irwindeep, Venner, Chritopher, Estey, Mathew

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Real-time prediction of myeloma clinical responses using an ex vivo, 3-dimensional culture system

    Real-time prediction of myeloma clinical responses using an ex vivo, 3-dimensional culture system by Chu, Michael, Debes-Marun, Carina, Sandhu, Irwindeep, Venner, Chritopher, Hewitt, Joanne, Belch, Andrew, Pilarski, Linda M.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Unusual Carfilzomib Toxicity: Three Cases of Drug-induced Thrombotic Microangiopathy (TMA) after Treatment with High-dose weekly Carfilzomib, Cyclophosphamide, and Dexamethasone (wCCD)

    Unusual Carfilzomib Toxicity: Three Cases of Drug-induced Thrombotic Microangiopathy (TMA) after Treatment with High-dose weekly Carfilzomib, Cyclophosphamide, and Dexamethasone (w... by Monteith, Bethany, Venner, Chritopher, Reece, Donna, Kew, Andrea, Lalancette, Marc, Garland, Jocelyn, Shepherd, Lois, McDonald, Gail, Gul, Engin, Pater, Joe, Hay, Annette

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    The Impact of Lenalidomide Maintenance on Second Line Chemotherapy in Transplant Eligible Patients with Multiple Myeloma in the Canadian Setting

    The Impact of Lenalidomide Maintenance on Second Line Chemotherapy in Transplant Eligible Patients with Multiple Myeloma in the Canadian Setting by Cherniawsky, Hannah, Kukreti, Vishal, Reece, Donna, Masih-Khan, Esther, MrCurdy, Arleigh, Jimenez-Zepeda, Victor, Sebag, Michael, Song, Kevin, White, Darrell, Stakiw, Julie, LeBlanc, Richard, Reiman, Tony, Aslam, Muhammad, Louzada, Martha, Kotb, Rami, Gul, Engin, Atenafu, Eshetu, Venner, Chritopher

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

    Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) by White, Darrell, LeBlanc, Richard, Venner, Chritopher, Bahlis, Nizar J., Lentzsch, Suzanne, Gasparetto, Cristina J., Chen, Christine, Lipe, Brea, Sutherland, Heather, Tuchman, Sascha, Baljevic, Muhamed, Kotb, Rami, Sebag, Michael, Callander, Nancy, Bensinger, William, Kai, Kazuharu, Liu, Jianjun, Sheehan, Heidi, Estepan, Daniel Nova, Shah, Jatin, Schiller, Gary J.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to Lenalidomide and Dexamethasone (LD) for the Treatment of Non-Transplant Eligible MM

    Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to Lenalidomide and Dexamethasone (LD) for the Treatment of Non-Transplant Eligible MM by Jimenez-Zepeda, Victor, Belch, Andrew R, Sandhu, Irwindeep, Bahlis, Nizar J, Duggan, Peter, Neri, Paola, Tay, Jason, Nikitina, Tatiana, Hewitt, Joanne, Venner, Chritopher

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: